Overview of the Global Cancer Immunotherapy Industry:
The Global Cancer Immunotherapy Market is projected to experience substantial growth between 2025 and 2030, driven by digital transformation, innovation in service delivery, and expanding demand. The Cancer Immunotherapy Market size was valued at around USD 134.4 billion in 2024 and is projected to reach USD 214.7 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.12% during the forecast period, i.e., 2025-30. This report offers an in-depth analysis of the key drivers, challenges, competitive landscape, and future outlook — helping businesses, investors, and stakeholders make informed decisions.
Market Size Forecast (2025–2030)
- Base Year: 2024
- Forecast Period: 2025–2030
- Estimated CAGR (2025–2030): 8.12%
Our Latest Reports Now Include In-Depth Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff Challenges with Greater Agility Get Sample Report - h https://www.marknteladvisors.com/query/request-sample/global-cancer-immunotherapy-market.html
Global Cancer Immunotherapy Market Driver:
Increasing Frequency of Approvals Received by Novel Immunotherapies - Increasing acceptance of novel immunotherapies is expected to bode well for market expansion in the coming years. For instance, The U.S. FDA authorized a number of anti-PD-1/L1 antibodies between 2020 and 2022 for the treatment of NSCLC, renal cell carcinoma, melanoma, breast, prostate, and other malignancies. These antibodies include nivolumab, atezolizumab, avelumab, dostarlimab, and others. Therefore, the increased approval of immunotherapeutic drugs has fueled market development in the past few years.
Top Companies in the Cancer Immunotherapy Market
Here’s a snapshot of key players leading innovation and market share:
- Amgen Inc.,
- Astrazeneca,
- Bayer AG,
- Bristol-Myers Squibb,
- ELI Lilly and Company,
- Janssen Global Services LLC
- Johnson and Johnson),
- Merck,
- Novartis,
- Pfizer, F.
- Hoffmann-La Roche AG
Includes SWOT analysis, revenue trends, partnerships, and product launches.
Explore Our Comprehensive Study: https://www.marknteladvisors.com/research-library/global-cancer-immunotherapy-market.html
Cancer Immunotherapy Market Segmentation Analysis
-By Cancer Type
- Lung Cancer
- Prostate Cancer
- Breast Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Head and Neck Cancer
- Melanoma
- Colorectal Cancer
The lung cancer segment is the leading cancer type in the global cancer immunotherapy market by revenue and market share.
-By Product Type
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies and Cancer Vaccines
- Checkpoint Inhibitors
- Others
-By Mechanism of Actions
- Active Immunotherapy
- Passive Immunotherapy
-By End Users
- Hospitals
- Cancer Research Centers
- Clinics
Geographical Analysis
-By Region
- North America
- Latin America
- Europe
- Middle East and Africa
- Asia-Pacific
North America led the overall market in terms of revenue owing to the presence of numerous key players and the various strategic initiatives they have undertaken.
Contact Our Analysts for Brochure Requests, Customization, or Any Pre-Purchase Inquiries: https://www.marknteladvisors.com/query/request-customization/global-cancer-immunotherapy-market.html
Methodology Behind the Report
This research combines qualitative and quantitative methods, including:
- Expert interviews
- Proprietary forecasting models
- Financial and trade databases
- Government and institutional data
Forecasts are validated using top-down and bottom-up approaches to ensure accuracy and reliability.
Frequently Asked Questions About the Cancer Immunotherapy Market
- What is the growth rate of the Cancer Immunotherapy market from 2025–2030?
- Which segment are expected to dominate market?
- Who are the top companies and what strategies being they using?
- What are the key risks and challenges in this industry?
- How can businesses prepare for future trends?
About Us –
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative quantitative research company, strive to deliver data to a substantial varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Media Contact:
Company Name: MarkNtel Advisors
Email: sales@marknteladvisors.com
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh - 201301, India
